Pivotal Bio Venture Partners Investment Advisor LLC Karuna Therapeutics, Inc. Transaction History

Pivotal Bio Venture Partners Investment Advisor LLC

$127 Million
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $2.47 Million - $3.27 Million	15,000 Added 1.92%	797,008 $135 Million
Q1 2023 May 12, 2023	BUY	$161.33 - $204.36 $2.6 Million - $3.29 Million	16,113 Added 2.1%	782,008 $142 Million
Q3 2022 Nov 10, 2022	SELL	$123.79 - $277.42 $14.3 Million - $32.1 Million	-115,563 Reduced 13.11%	765,895 $172 Million
Q2 2022 Aug 12, 2022	BUY	$93.97 - $143.33 $2.7 Million - $4.12 Million	28,750 Added 3.37%	881,458 $112 Million
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $6.02 Million - $7.61 Million	-56,000 Reduced 6.16%	852,708 $97.2 Million
Q1 2021 May 14, 2021	SELL	$95.46 - $133.08 $16.7 Million - $23.2 Million	-174,636 Reduced 16.12%	908,708 $109 Million
Q4 2020 Feb 09, 2021	BUY	$75.23 - $109.23 $81.5 Million - $118 Million	1,083,344 New	1,083,344 $110 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.

Account